More than just hype
RJ Sigal - CMAJ, 2003 - Can Med Assoc
1. Pilote L. Ramipril use in Canada: HOPE or HYPE?[editorial]. CMAJ 2003; 168 (5): 568-9.
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
[PDF][PDF] More than just hype
W Shishkov - CMAJ, 2003 - Can Med Assoc
1. Pilote L. Ramipril use in Canada: HOPE or HYPE?[editorial]. CMAJ 2003; 168 (5): 568-9.
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
More than just hype
L Pilote - CMAJ, 2003 - Can Med Assoc
1. Pilote L. Ramipril use in Canada: HOPE or HYPE?[editorial]. CMAJ 2003; 168 (5): 568-9.
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …
[HTML][HTML] Ramipril use in Canada: HOPE or HYPE?
L Pilote - CMAJ, 2003 - Can Med Assoc
Correspondence to: Dr. Monika Naus, Associate Director, Epidemiology Services, BC
Centre for Disease Control, 2nd floor, 655 W 12th Ave., Vancouver BC V5Z 4R4; fax 604 660 …
Centre for Disease Control, 2nd floor, 655 W 12th Ave., Vancouver BC V5Z 4R4; fax 604 660 …
[PDF][PDF] The HOPE study and diabetes
M Stubanus, D Endemann, M Fischereder, KP Ittner… - The Lancet, 2000 - thelancet.com
1 Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on
cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the …
cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the …
[HTML][HTML] The HOPE study and diabetes
HC Gerstein, S Yusuf - The Lancet, 2000 - thelancet.com
1 Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on
cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the …
cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the …
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension
Hope/Hope-Too Study Investigators - Circulation, 2005 - Am Heart Assoc
Background—We have previously demonstrated that ramipril reduces vascular events and
new diagnoses of diabetes when given for a 4.5-year period. However, it is not known …
new diagnoses of diabetes when given for a 4.5-year period. However, it is not known …
The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario
K Tu, MM Mamdani, RM Jacka, NJ Forde, DM Rothwell… - Cmaj, 2003 - Can Med Assoc
Background: The Heart Outcomes Prevention Evaluation (HOPE), a Canadian-led,
multicentre, randomized controlled trial, demonstrated the effectiveness of the ACE inhibitor …
multicentre, randomized controlled trial, demonstrated the effectiveness of the ACE inhibitor …
What is the relevance of the hope study in general practice?
J Kennedy, CE Mogensen, SG Ball… - … journal of clinical …, 2001 - Wiley Online Library
The unique findings from the HOPE (Heart Outcomes Prevention Evaluation) study strongly
support extending the use of the angiotensin‐converting enzyme (ACE) inhibitor ramipril as …
support extending the use of the angiotensin‐converting enzyme (ACE) inhibitor ramipril as …
[CITATION][C] Ramipril is cost-effective in preventing cardiovascular events in patients with diabetes mellitus
R Ganguly, TV Parasuraman - Journal of the American College of …, 2003 - jacc.org
Background: Heart Outcomes Prevention Evaluation (HOPE) study and MICRO-HOPE sub-
study showed significant mortality and morbidity benefits associated with the angiotensin …
study showed significant mortality and morbidity benefits associated with the angiotensin …